Skip to Content Skip to Search


We have around 80 employees who work to make a wide range of prescription drugs and vaccines available to as many people as possible in Austria.

We are a leader in the innovative treatment of respiratory diseases, with our current focus on severe asthma.

We focus our innovative transformational oncology medicines on maximising the survival chances of people with cancer. Our current focus areas are ovarian cancer, endometrial cancer and multiple myeloma.

With our broad and innovative HIV portfolio, we are committed to making progress in the treatment and care of people living with HIV and those at risk of becoming infected with HIV. Our current focus is on 2DRs (2-drug regimens) and long-acting injectable treatment for HIV.

LiVLife is a platform for people living with HIV. Most importantly, it is a platform co-developed by people living with HIV to clarify the most important questions about HIV, to learn from each other and to support each other.

As a leading vaccine company in Austria and worldwide, we protect people of all ages from a variety of diseases with our broad portfolio of paediatric and adult vaccines.

You can find more information about meningococcal disease and protection options at

More information about our pharmaceutical products, vaccines and consumer healthcare products can be found on our global website.

Family group running all vaccinated against childhood disease

GlaxoSmithKline Pharma GmbH
Wienerbergstraße 7, 5. Stock
1100 Wien
Tel: +43 1 970 75-0
Fax: +43 1 970 75-170

Company register: FN 115955y, Handelsgericht Wien
UID: ATU 14215008
Members of WKÖ, Pharmig and FOPI

Reporting an adverse event

Please use the form to report an adverse reaction or write to


Find out how you can become part of our company. Search for jobs in Austria

Media enquiries

Mag. Barbara Masser-Mayerl
Corporate Communications Lead
Tel: + 43 664 8270120

You can find our current press releases here in our pressroom. Due to the prohibition of advertising for prescription drugs (AMG), we cannot publish any information or press releases about our products here. If you cannot find the information you are looking for, please contact us.

Healthcare professionals

As a healthcare company, we regularly work with medical professionals. Transparency and integrity are paramount in all our interactions.

GSKPro, our portal for healthcare professionals, provides important information about our products, access to videos and webcasts, and access to educational events and other GSK services.


GlaxoSmithKline (GSK), a member of Transparency International Austria, already took a number of transparency initiatives many years ago that go beyond the usual industry standards. Following the introduction of the first online register of clinical trial results by GSK in 2004 and the publication of payments to patient groups since 2006, all monetary benefits paid to healthcare professionals' relatives and institutions have been disclosed annually since 2016 - in accordance with the EFPIA Disclosure Code.

Memberships and Partnerships

We are a member of ​​Pharmig (Association of Pharmaceutical Industry in Austria), FOPI (Forum of the researching pharmaceutical industry in Austria) and WKÖ (Chamber of Commerce). 

We are a member of Transparency International Austrian Chapter

We are member of respACT (Austrian Business Council for Sustainable Development)

Our activities in the area of lobbying and representation of interests are based on the code of conduct of the Austrian Public Affairs Association (ÖPAV).

NP-AT-NA-WCNT-220001; 07/2022

Back to top